KRYS
Krystal Biotech, Inc.
Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer
Total Trades
60
Buys
0
Sells
48
Largest Trade
N/A
Insiders
8
Institutional Funds
283
Inst. Value
$1M+
Activist Filings
16
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| ROMANO KATHRYN | Chief Accounting O… | SELL | $100K–$500K | 750 | $267.60 | Mar 3, 2026 |
| ROMANO KATHRYN | Chief Accounting O… | EXERCISE | N/A | 8K | — | Mar 3, 2026 |
| JANNEY DANIEL | Director | SELL | $1M+ | 12K | $275.59 | Mar 3, 2026 |
| JANNEY DANIEL | Director | EXERCISE | $50K–$100K | 38K | $2.46 | Feb 26, 2026 |
| JANNEY DANIEL | Director | SELL | $1M+ | 60K | $268.44 | Feb 26, 2026 |
| ROSSI DINO A | Director | SELL | $1M+ | 19K | $261.41 | Feb 24, 2026 |
| ROSSI DINO A | Director | EXERCISE | $100K–$500K | 19K | $8.79 | Feb 24, 2026 |
| ROMANO KATHRYN | Chief Accounting O… | SELL | $1M+ | 13K | $272.14 | Feb 12, 2026 |
| ROMANO KATHRYN | Chief Accounting O… | EXERCISE | $500K+ | 13K | $63.55 | Feb 12, 2026 |
| Krishnan Suma | President, R&D | SELL | $1M+ | 50K | $220.15 | Dec 5, 2025 |
| Krishnan Krish S | President and CEO | SELL | $1M+ | 50K | $220.15 | Dec 5, 2025 |
| Krishnan Suma | President, R&D | SELL | $1M+ | 36K | $150.39 | Jul 16, 2025 |
| Krishnan Krish S | President and CEO | SELL | $1M+ | 36K | $150.39 | Jul 16, 2025 |
| Krishnan Suma | President, R&D | SELL | $1M+ | 14K | $150.27 | Jul 11, 2025 |
| Krishnan Krish S | President and CEO | SELL | $1M+ | 14K | $150.27 | Jul 11, 2025 |
| Krishnan Suma | President, R&D | SELL | $1M+ | 50K | $177.79 | Mar 13, 2025 |
| Krishnan Krish S | President and CEO | SELL | $1M+ | 50K | $177.79 | Mar 13, 2025 |
| ROMANO KATHRYN | Chief Accounting O… | SELL | $100K–$500K | 750 | $175.22 | Mar 1, 2025 |
| ROMANO KATHRYN | Chief Accounting O… | EXERCISE | N/A | 13K | — | Mar 1, 2025 |
| Krishnan Suma | President, R&D | SELL | $1M+ | 50K | $175.76 | Jun 12, 2024 |
| Krishnan Krish S | President and CEO | SELL | $1M+ | 50K | $175.76 | Jun 12, 2024 |
| Gangolli Julian S | Director | EXERCISE | $100K–$500K | 20K | $22.75 | May 22, 2024 |
| Gangolli Julian S | Director | SELL | $1M+ | 20K | $164.13 | May 22, 2024 |
| ROMANO KATHRYN | Chief Accounting O… | SELL | $500K+ | 5K | $165.88 | Mar 2, 2024 |
| ROMANO KATHRYN | Chief Accounting O… | EXERCISE | $100K–$500K | 10K | $31.77 | Mar 2, 2024 |
| ROMANO KATHRYN | Chief Accounting O… | SELL | $1M+ | 8K | $166.05 | Mar 2, 2024 |
| ROMANO KATHRYN | Chief Accounting O… | EXERCISE | $100K–$500K | 8K | $63.55 | Mar 2, 2024 |
| ROMANO KATHRYN | Chief Accounting O… | EXERCISE | $500K+ | 10K | $52.26 | Feb 29, 2024 |
| ROMANO KATHRYN | Chief Accounting O… | SELL | $1M+ | 8K | $136.91 | Feb 29, 2024 |
| Romano Kathryn | Chief Accounting O… | SELL | $100K–$500K | 3K | $130.00 | Jan 24, 2024 |
| Romano Kathryn | Chief Accounting O… | EXERCISE | $100K–$500K | 3K | $52.26 | Jan 24, 2024 |
| Krishnan Suma | President, R&D | SELL | $1M+ | 50K | $127.23 | Sep 12, 2023 |
| Krishnan Krish S | President and CEO | SELL | $1M+ | 50K | $127.23 | Sep 12, 2023 |
| JANNEY DANIEL | Director | SELL | $1M+ | 50K | $128.36 | Jun 9, 2023 |
| ORTH ANDREW C. | Chief Commercial O… | SELL | $1M+ | 13K | $128.61 | Jun 9, 2023 |
| ORTH ANDREW C. | Chief Commercial O… | EXERCISE | $500K+ | 13K | $63.55 | Jun 9, 2023 |
| Krishnan Suma | President, R&D | SELL | $1M+ | 50K | $116.20 | Jun 2, 2023 |
| Krishnan Krish S | President and CEO | SELL | $1M+ | 50K | $116.20 | Jun 2, 2023 |
| Romano Kathryn | Chief Accounting O… | SELL | $1M+ | 53K | $101.60 | May 23, 2023 |
| Romano Kathryn | Chief Accounting O… | EXERCISE | $1M+ | 50K | $55.08 | May 23, 2023 |
| JANNEY DANIEL | Director | SELL | $1M+ | 50K | $95.02 | May 23, 2023 |
| JANNEY DANIEL | Director | SELL | $1M+ | 17K | $90.74 | May 11, 2023 |
| JANNEY DANIEL | Director | SELL | $500K+ | 8K | $90.32 | Apr 21, 2023 |
| Krishnan Suma | President, R&D | SELL | $1M+ | 50K | $87.65 | Apr 18, 2023 |
| Krishnan Krish S | President and CEO | SELL | $1M+ | 50K | $87.65 | Apr 18, 2023 |
| ROSSI DINO A | Director | SELL | $1M+ | 40K | $83.25 | Mar 2, 2023 |
| Krishnan Suma | President, R&D | SELL | $1M+ | 50K | $80.79 | Jan 19, 2023 |
| Krishnan Krish S | President and CEO | SELL | $1M+ | 50K | $80.79 | Jan 19, 2023 |
| Krishnan Suma | President, R&D | SELL | $500K+ | 8K | $80.08 | Jan 5, 2023 |
| Krishnan Krish S | President and CEO | SELL | $500K+ | 8K | $80.08 | Jan 5, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 283 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 2.6M | $1M+ | SH |
| STATE STREET CORP | 1.3M | $1M+ | SH |
| Soleus Capital Management, L.P. | 941K | $1M+ | SH |
| Capital World Investors | 810K | $1M+ | SH |
| Redmile Group, LLC | 678K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 530K | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 488K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 468K | $1M+ | SH |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 376K | $1M+ | SH |
| NORGES BANK | 285K | $1M+ | SH |
| FIRST TRUST ADVISORS LP | 245K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 243K | $1M+ | SH |
| BRAIDWELL LP | 202K | $1M+ | SH |
| MARSHALL WACE, LLP | 184K | $1M+ | SH |
| Pictet Asset Management Holding SA | 157K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 120K | $1M+ | SH |
| Handelsbanken Fonder AB | 106K | $1M+ | SH |
| TimesSquare Capital Management, LLC | 97K | $1M+ | SH |
| S Squared Technology, LLC | 96K | $1M+ | SH |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 89K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 5, 2025
4.4%
1.3M shares
SC 13G/A · Nov 15, 2024
2.8%
810K shares
SC 13G/A · Nov 12, 2024
14.9%
4.3M shares
STATE STREET CORPORATION 04-2456637
SC 13G · Oct 16, 2024
5.1%
1.5M shares
The Vanguard Group - 23-1945930
SC 13G/A · Jul 10, 2024
10.1%
2.9M shares
SC 13G/A · Jul 8, 2024
13.8%
3.9M shares
SC 13G/A · Feb 14, 2024
6.1%
1.7M shares
SC 13G/A · Feb 14, 2024
9.1%
2.6M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
8.6%
2.4M shares
SC 13G/A · Feb 12, 2024
11.9%
3.3M shares
SC 13G/A · Jan 29, 2024
6.4%
1.8M shares
SC 13G/A · May 10, 2023
10.1%
2.6M shares
SC 13G/A · Feb 14, 2023
7.4%
1.9M shares
SC 13G · Feb 14, 2023
5.5%
1.4M shares
SC 13G/A · Jan 31, 2023
6.6%
1.7M shares
SC 13G/A · Feb 14, 2022
7.3%
1.8M shares